Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Encord is a private software company that provides a multimodal data infrastructure, annotation, curation, and evaluation platform for AI teams. Its core business is enabling customers to manage, label, review, and align complex data types including video, image, audio, text, LiDAR, documents, and medical imaging formats such as DICOM and NIfTI. Although not a drug developer or therapeutic company, Encord is healthcare-relevant because it offers HIPAA-compliant tooling and medical imaging workflows used by healthcare AI and clinical imaging teams. The company serves a broad set of sectors including healthcare, robotics, autonomous systems, and enterprise AI, and appears to be commercially mature rather than operating a therapeutic pipeline. Recent financing and customer traction suggest it is an active growth-stage private company building infrastructure for production AI.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Encord.